Title,Authors,Platform,Cited_url,Cited_count,Year
Highly efficient endogenous human gene correction using designed zinc-finger nucleases,"FD Urnov, JC Miller, YL Lee, CM Beausejour, JM Rock, S Augustus, ...","Nature 435 (7042), 646",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3825712259271676603,1689,2005
Chimeric nucleases stimulate gene targeting in human cells,"MH Porteus, D Baltimore","Science 300 (5620), 763-763",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17550282381294905985,828,2003
Rapid “open-source” engineering of customized zinc-finger nucleases for highly efficient gene modification,"ML Maeder, S Thibodeau-Beganny, A Osiak, DA Wright, RM Anthony, ...","Molecular cell 31 (2), 294-301",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11489838952588615134,784,2008
Gene targeting using zinc finger nucleases,"MH Porteus, D Carroll","Nature biotechnology 23 (8), 967",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8221513961349378602,714,2005
"Spatially restricted expression of Dlx-1, Dlx-2 (Tes-1), Gbx-2, and Wnt-3 in the embryonic day 12.5 mouse forebrain defines potential transverse and longitudinal segmental …","A Bulfone, L Puelles, MH Porteus, MA Frohman, GR Martin, ...","Journal of Neuroscience 13 (7), 3155-3172",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16891776814791873145,572,1993
Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells,"J Zou, ML Maeder, P Mali, SM Pruett-Miller, S Thibodeau-Beganny, ...","Cell stem cell 5 (1), 97-110",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=80422438237828226,531,2009
Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells,"S Durai, M Mani, K Kandavelou, J Wu, MH Porteus, S Chandrasegaran","Nucleic acids research 33 (18), 5978-5990",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=265846320131800758,521,2005
Activation of proto-oncogenes by disruption of chromosome neighborhoods,"D Hnisz, AS Weintraub, DS Day, AL Valton, RO Bak, CH Li, J Goldmann, ...","Science 351 (6280), 1454-1458",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13512287493688682051,430,2016
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells,"A Hendel, RO Bak, JT Clark, AB Kennedy, DE Ryan, S Roy, I Steinfeld, ...","Nature biotechnology 33 (9), nbt. 3290",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11210118010482596416,428,2015
"Transplantation outcomes for severe combined immunodeficiency, 2000–2009","SY Pai, BR Logan, LM Griffith, RH Buckley, RE Parrott, CC Dvorak, ...","New England Journal of Medicine 371 (5), 434-446",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7471206421802212616,386,2014
Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States,"A Kwan, RS Abraham, R Currier, A Brower, K Andruszewski, JK Abbott, ...","Jama 312 (7), 729-738",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15754046781326574225,385,2014
An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level,"DE Bauer, SC Kamran, S Lessard, J Xu, Y Fujiwara, C Lin, Z Shao, ...","Science 342 (6155), 253-257",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16892154433930200934,381,2013
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells,"DP Dever, RO Bak, A Reinisch, J Camarena, G Washington, CE Nicolas, ...","Nature 539 (7629), 384",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=725515383882003880,341,2016
Use of chimeric nucleases to stimulate gene targeting,"D Baltimore, M Porteus","US Patent 9,447,434",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6904131632862786197,261,2016
MOF and histone H4 acetylation at lysine 16 are critical for DNA damage response and double-strand break repair,"GG Sharma, S So, A Gupta, R Kumar, C Cayrou, N Avvakumov, U Bhadra, ...","Molecular and cellular biology 30 (14), 3582-3595",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8460550401189987213,239,2010
Isolation and characterization of a novel cDNA clone encoding a homeodomain that is developmentally regulated in the ventral forebrain,"MH Porteus, A Bulfone, RD Ciaranello, JLR Rubenstein","Neuron 7 (2), 221-229",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17262341201120979636,225,1991
Human SMC5/6 complex promotes sister chromatid homologous recombination by recruiting the SMC1/3 cohesin complex to double‐strand breaks,"PR Potts, MH Porteus, H Yu","The EMBO journal 25 (14), 3377-3388",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12356120394216660991,223,2006
"The mouse Dlx-2 (Tes-1) gene is expressed in spatially restricted domains of the forebrain, face and limbs in midgestation mouse embryos","A Bulfone, HJ Kim, L Puelles, MH Porteus, JF Grippo, JLR Rubenstein","Mechanisms of development 40 (3), 129-140",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5308335146170337653,222,1993
Standardized reagents and protocols for engineering zinc finger nucleases by modular assembly,"DA Wright, S Thibodeau-Beganny, JD Sander, RJ Winfrey, AS Hirsh, ...","Nature protocols 1 (3), 1637",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13530046900401864842,221,2006
Mammalian gene targeting with designed zinc finger nucleases,MH Porteus,"Molecular Therapy 13 (2), 438-446",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16396616632373656112,214,2006
"DLX-2, MASH-1, and MAP-2 expression and bromodeoxyuridine incorporation define molecularly distinct cell populations in the embryonic mouse forebrain","MH Porteus, A Bulfone, JK Liu, L Puelles, LC Lo, JL Rubenstein","Journal of Neuroscience 14 (11), 6370-6383",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3550096062383732086,213,1994
"Spermatogonial stem cell self‐renewal requires OCT4, a factor downregulated during retinoic acid‐induced differentiation","CT Dann, AL Alvarado, LA Molyneux, BS Denard, DL Garbers, ...","Stem cells 26 (11), 2928-2937",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11855448008490516203,184,2008
Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks,"MH Porteus, T Cathomen, MD Weitzman, D Baltimore","Molecular and cellular biology 23 (10), 3558-3565",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16974220008968967412,179,2003
Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years,"A Kwan, JA Church, MJ Cowan, R Agarwal, N Kapoor, DB Kohn, ...","Journal of Allergy and Clinical Immunology 132 (1), 140-150. e7",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12334178194187981955,168,2013
Attenuation of zinc finger nuclease toxicity by small-molecule regulation of protein levels,"SM Pruett-Miller, DW Reading, SN Porter, MH Porteus","PLoS genetics 5 (2), e1000376",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10731164620034535206,152,2009
Identification of preexisting adaptive immunity to Cas9 proteins in humans,"CT Charlesworth, PS Deshpande, DP Dever, J Camarena, VT Lemgart, ...","Nature medicine 25 (2), 249",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13907974922031837181,150,2019
Comparison of zinc finger nucleases for use in gene targeting in mammalian cells,"SM Pruett-Miller, JP Connelly, ML Maeder, JK Joung, MH Porteus","Molecular Therapy 16 (4), 707-717",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10003565428673109261,149,2008
Promoterless gene targeting without nucleases ameliorates haemophilia B in mice,"A Barzel, NK Paulk, Y Shi, Y Huang, K Chu, F Zhang, PN Valdmanis, ...","Nature 517 (7534), 360",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5345831264950524730,135,2015
Subtractive hybridization system using single-stranded phagemids with directional inserts,"JLR Rubenstein, AEJ Brice, RD Ciaranello, D Denney, MH Porteus, ...","Nucleic acids research 18 (16), 4833-4842",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5073949576430863532,129,1990
"Sequence, Organization, and Transcription of theDlx-1andDlx-2Locus","T McGuinness, MH Porteus, S Smiga, A Bulfone, C Kingsley, M Qiu, ...","Genomics 35 (3), 473-485",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3128831299828453340,108,1996
Quantifying on-and off-target genome editing,"A Hendel, EJ Fine, G Bao, MH Porteus","Trends in biotechnology 33 (2), 132-140",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1718726012746337049,105,2015
Phosphorylation of EXO1 by CDKs 1 and 2 regulates DNA end resection and repair pathway choice,"N Tomimatsu, B Mukherjee, MC Hardebeck, M Ilcheva, CV Camacho, ...","Nature communications 5, 3561",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8572075356689333850,104,2014
Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis,"N Gomez-Ospina, CJ Potter, R Xiao, K Manickam, MS Kim, KH Kim, ...","Nature communications 7, 10713",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10457220741250366723,103,2016
Quantifying genome-editing outcomes at endogenous loci with SMRT sequencing,"A Hendel, EJ Kildebeck, EJ Fine, JT Clark, N Punjya, V Sebastiano, ...","Cell reports 7 (1), 293-305",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3208018489484811481,103,2014
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells,"CA Vakulskas, DP Dever, GR Rettig, R Turk, AM Jacobi, MA Collingwood, ...","Nature medicine 24 (8), 1216",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2217524100885762423,97,2018
Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms’ tumor: a report from the National Wilms Tumor Study Group,"MH Porteus, P Narkool, D Neuberg, K Guthrie, N Breslow, DM Green, ...","Journal of Clinical Oncology 18 (10), 2026-2031",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8220853033937964709,93,2000
Nuclease-mediated gene editing by homologous recombination of the human globin locus,"RA Voit, A Hendel, SM Pruett-Miller, MH Porteus","Nucleic acids research 42 (2), 1365-1378",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9198554579692884214,90,2013
A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno …,"BL Ellis, ML Hirsch, JC Barker, JP Connelly, RJ Steininger, MH Porteus","Virology journal 10 (1), 74",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=128935844292709836,87,2013
Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs,"BL Ellis, ML Hirsch, SN Porter, RJ Samulski, MH Porteus","Gene therapy 20 (1), 35",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11226876880113355163,87,2013
A look to future directions in gene therapy research for monogenic diseases,"MH Porteus, JP Connelly, SM Pruett","PLoS genetics 2 (9), e133",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5968404722327428402,87,2006
"Genome Editing Technologies: Defining a Path to Clinic: Genomic Editing: Establishing Preclinical Toxicology Standards, Bethesda, Maryland 10 June 2014","J Corrigan-Curay, M O'reilly, DB Kohn, PM Cannon, G Bao, FD Bushman, ...","Molecular Therapy 23 (5), 796-806",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9150770594814345376,68,2015
Generation of an HIV resistant T-cell line by targeted “stacking” of restriction factors,"RA Voit, MA McMahon, SL Sawyer, MH Porteus","Molecular Therapy 21 (4), 786-795",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10224261422991705697,67,2013
Gene correction by homologous recombination with zinc finger nucleases in primary cells from a mouse model of a generic recessive genetic disease,"JP Connelly, JC Barker, S Pruett-Miller, MH Porteus","Molecular therapy 18 (6), 1103-1110",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8038514224495143786,64,2010
Editing the genome to introduce a beneficial naturally occurring mutation associated with increased fetal globin,"B Wienert, APW Funnell, LJ Norton, RCM Pearson, LE Wilkinson-White, ...","Nature communications 6, 7085",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9573097823955675726,61,2015
Gene editing: not just for translation anymore,"MA McMahon, M Rahdar, M Porteus","Nature methods 9 (1), 28",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17797970558222974582,59,2012
Genome editing: a new approach to human therapeutics,M Porteus,"Annual review of pharmacology and toxicology 56, 163-190",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8454451571549365934,57,2016
Towards a new era in medicine: therapeutic genome editing,MH Porteus,"Genome biology 16 (1), 286",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6331997048853772504,52,2015
SAPTA: a new design tool for improving TALE nuclease activity,"Y Lin, EJ Fine, Z Zheng, CJ Antico, RA Voit, MH Porteus, TJ Cradick, ...","Nucleic acids research 42 (6), e47-e47",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17118720592626106735,52,2014
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus,"C Antoniani, V Meneghini, A Lattanzi, T Felix, O Romano, E Magrin, ...","Blood 131 (17), 1960-1973",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9876851431748221487,49,2018
Creating higher titer lentivirus with caffeine,"BL Ellis, PR Potts, MH Porteus","Human gene therapy 22 (1), 93-100",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=574108413055642961,47,2010
Isolation and characterization of a library of cDNA clones that are preferentially expressed in the embryonic telencephalon,"MH Porteus, AEJ Brice, A Bulfone, TB Usdin, RD Ciaranello, ...","Molecular brain research 12 (1-3), 7-22",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2526853873766557107,45,1992
CRISPR/Cas9 genome editing in human hematopoietic stem cells,"RO Bak, DP Dever, MH Porteus","Nature protocols 13 (2), 358",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10820087076859526414,44,2018
CRISPR-mediated integration of large gene cassettes using AAV donor vectors,"RO Bak, MH Porteus","Cell reports 20 (3), 750-756",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9071101166406085835,44,2017
Design and testing of zinc finger nucleases for use in mammalian cells,M Porteus,"Chromosomal Mutagenesis, 47-61",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3352847229628327165,44,2008
Lentiviral and targeted cellular barcoding reveals ongoing clonal dynamics of cell lines in vitro and in vivo,"SN Porter, LC Baker, D Mittelman, MH Porteus","Genome biology 15 (5), R75",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17206924025896663796,41,2014
Self-complementary AAV mediates gene targeting and enhances endonuclease delivery for double-strand break repair,"ML Hirsch, L Green, MH Porteus, RJ Samulski","Gene therapy 17 (9), 1175",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=394769249258011010,40,2010
Receptor-mediated delivery of engineered nucleases for genome modification,"Z Chen, L Jaafar, DG Agyekum, H Xiao, MF Wade, RI Kumaran, ...","Nucleic acids research 41 (19), e182-e182",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13990685729328198991,39,2013
Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6,"RO Bak, DP Dever, A Reinisch, DC Hernandez, R Majeti, MH Porteus","Elife 6, e27873",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11080840987514276546,37,2017
MLL leukemia induction by genome editing of human CD34+ hematopoietic cells,"C Buechele, EH Breese, D Schneidawind, CH Lin, J Jeong, ...","Blood 126 (14), 1683-1694",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16543438314909779211,37,2015
Plant biotechnology: zinc fingers on target,MH Porteus,"Nature 459 (7245), 337",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12943996301678146313,36,2009
"DLX2 (TES1), a homeobox gene of the Distal-less family, assigned to conserved regions on human and mouse chromosomes 2","T Özçelik, MH Porteus, JLR Rubenstein, U Francke","Genomics 13 (4), 1157-1161",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11681429373426932371,36,1992
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery,"E Haddad, BR Logan, LM Griffith, RH Buckley, RE Parrott, SE Prockop, ...","Blood 132 (17), 1737-1749",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9833133473618723346,35,2018
Stem cell-specific mechanisms ensure genomic fidelity within HSCs and upon aging of HSCs,"BM Moehrle, K Nattamai, A Brown, MC Florian, M Ryan, M Vogel, ...","Cell reports 13 (11), 2412-2424",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15680292608446324475,32,2015
Genome editing of the germline: broadening the discussion,"MH Porteus, CT Dann","Molecular Therapy 23 (6), 980-982",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=373086872428226677,32,2015
Using homologous recombination to manipulate the genome of human somatic cells,M Porteus,"Biotechnology and Genetic Engineering Reviews 24 (1), 195-212",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8112879612466239580,32,2007
Development of nuclease-mediated site-specific genome modification,"SE Wirt, MH Porteus","Current opinion in immunology 24 (5), 609-616",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6494830073434224700,31,2012
Ethical and regulatory aspects of genome editing,"DB Kohn, MH Porteus, AM Scharenberg","Blood, The Journal of the American Society of Hematology 127 (21), 2553-2560",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16279344459198055850,30,2016
A comprehensive TALEN-based knockout library for generating human-induced pluripotent stem cell–based models for cardiovascular diseases,"I Karakikes, V Termglinchan, DA Cepeda, J Lee, S Diecke, A Hendel, ...","Circulation research 120 (10), 1561-1571",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16966572770208397560,29,2017
Viral single-strand DNA induces p53-dependent apoptosis in human embryonic stem cells,"ML Hirsch, BM Fagan, R Dumitru, JJ Bower, S Yadav, MH Porteus, ...","PLoS One 6 (11), e27520",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10737068446001295056,29,2011
Benefits of utilizing gene-modified iPSCs for clinical applications,"J Ellis, C Baum, N Benvenisty, G Mostoslavsky, H Okano, WL Stanford, ...","Cell Stem Cell 7 (4), 429-430",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3421624030036955616,27,2010
Genome editing in cardiovascular biology,"T Seeger, M Porteus, JC Wu","Circulation research 120 (5), 778-780",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11627732673881206934,25,2017
TALENs facilitate single-step seamless SDF correction of F508del CFTR in airway epithelial submucosal gland cell-derived CF-iPSCs,"S Suzuki, RG Sargent, B Illek, H Fischer, A Esmaeili-Shandiz, MJ Yezzi, ...","Molecular Therapy-Nucleic Acids 5, e273",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8378230019351957739,23,2016
Genome editing in mouse spermatogonial stem/progenitor cells using engineered nucleases,"DA Fanslow, SE Wirt, JC Barker, JP Connelly, MH Porteus, CT Dann","PLoS One 9 (11), e112652",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6552361443370911512,23,2014
Design and development of artificial zinc finger transcription factors and zinc finger nucleases to the hTERT locus,"KA Wilson, ML Chateau, MH Porteus","Molecular Therapy-Nucleic Acids 2, e87",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=590426041905516680,23,2013
Validation of a model of non-rhegmatogenous retinal detachment,"MF Marmor, M Porteus, A Negi, J Immel","Current eye research 3 (3), 515-518",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4652505247792564986,23,1984
Gene editing on center stage,"RO Bak, N Gomez-Ospina, MH Porteus","Trends in Genetics 34 (8), 600-611",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10848119240384042540,22,2018
The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation.,"DP Dever, MH Porteus","Current opinion in hematology 24 (6), 481-488",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15919610996743713685,20,2017
Expanding the repertoire of target sites for zinc finger nuclease-mediated genome modification,"KA Wilson, AE McEwen, SM Pruett-Miller, J Zhang, EJ Kildebeck, ...","Molecular Therapy-Nucleic Acids 2, e88",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2436597842697055153,20,2013
Gene correction for SCID-X1 in long-term hematopoietic stem cells,"M Pavel-Dinu, V Wiebking, BT Dejene, W Srifa, S Mantri, CE Nicolas, ...","Nature communications 10 (1), 1634","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5226605486968163180,9769426090843940826",18,2019
Use of genome engineering to create patient specific MLL translocations in primary human hematopoietic stem and progenitor cells,"EH Breese, C Buechele, C Dawson, ML Cleary, MH Porteus","PloS one 10 (9), e0136644",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4102676240192347036,18,2015
A new class of medicines through DNA editing,MH Porteus,"New England Journal of Medicine 380 (10), 947-959",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17948350142026650826,16,2019
Gene therapy for primary immunodeficiencies,"E Kildebeck, J Checketts, M Porteus","Current opinion in pediatrics 24 (6), 731-738",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11664011860727991199,16,2012
Improved outcomes after autologous bone marrow transplantation for children with relapsed or refractory Hodgkin lymphoma: twenty years experience at a single institution,"PM Garfin, MP Link, SS Donaldson, RH Advani, S Luna-Fineman, ...","Biology of Blood and Marrow Transplantation 21 (2), 326-334",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2716810134228727946,15,2015
Global transcriptional response to CRISPR/Cas9-AAV6-based genome editing in CD34+ hematopoietic stem and progenitor cells,"MK Cromer, S Vaidyanathan, DE Ryan, B Curry, AB Lucas, J Camarena, ...","Molecular Therapy 26 (10), 2431-2442",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12384175240790617968,14,2018
Priming human repopulating hematopoietic stem and progenitor cells for Cas9/sgRNA gene targeting,"CT Charlesworth, J Camarena, MK Cromer, S Vaidyanathan, RO Bak, ...","Molecular Therapy-Nucleic Acids 12, 89-104",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14812083858141303204,14,2018
Gene/cell therapy approaches for immune dysregulation polyendocrinopathy enteropathy X-linked syndrome,"L Passerini, F R Santoni de Sio, M H Porteus, R Bacchetta","Current gene therapy 14 (6), 422-428",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14946484795038503275,14,2014
A crisper look at genome editing: RNA-guided genome modification,"M Damian, MH Porteus","Molecular Therapy 21 (4), 720-722",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15067802445438793087,14,2013
Homologous recombination‐based gene therapy for the primary immunodeficiencies,M Porteus,"Annals of the New York Academy of Sciences 1246 (1), 131-140",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18403044911669816648,14,2011
Toward responsible human genome editing,"RO Hynes, BS Coller, M Porteus","Jama 317 (18), 1829-1830",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2314251664707942215,12,2017
Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases,"JP Tremblay, X Xiao, A Aartsma-Rus, C Barbas, HM Blau, AJ Bogdanove, ...","Molecular Therapy 21 (2), 266-268",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11361910520899110827,12,2013
Genome editing of mouse fibroblasts by homologous recombination for sustained secretion of PDGF-B and augmentation of wound healing,"JC Barker, AD Barker, J Bills, J Huang, M Wight-Carter, I Delgado, ...","Plastic and reconstructive surgery 134 (3), 389e-401e",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16817419478517764922,11,2014
MLL leukemia induction by t (9; 11) chromosomal translocation in human hematopoietic stem cells using genome editing,"C Schneidawind, J Jeong, D Schneidawind, IS Kim, J Duque-Afonso, ...","Blood advances 2 (8), 832-845",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13400522837812837461,10,2018
Phosphorylation of residues inside the SNARE complex suppresses secretory vesicle fusion,"S Malmersjö, S Di Palma, J Diao, Y Lai, RA Pfuetzner, AL Wang, ...","The EMBO journal 35 (16), 1810-1821",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=149890493165244109,10,2016
"CRISPR/Cas9 Genome Editing to Treat Sickle Cell Disease and B-Thalassemia: Re-Creating Genetic Variants to Upregulate Fetal Hemoglobin Appear Well-Tolerated, Effective and Durable.","MI Lin, E Paik, B Mishra, D Burkhardt, A Kernytsky, M Pettiglio, YS Chen, ...","Blood 130 (Suppl 1), 284-284",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6586450290666321166,9,2017
Zinc fingers hit off target.,"L Cheng, B Blazar, K High, M Porteus","Nature medicine 17 (10), 1192-1193",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7594379694657767377,9,2011
A partial cDNA sequence of the Dlx-2 cDNA.,"MH Porteus, A Bulfone, RD Ciaranello, JL Rubenstein","Neuron 9 (1), 187",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=877641477493174313,9,1992
Genome editing of the blood: opportunities and challenges,MH Porteus,"Current stem cell reports 1 (1), 23-30",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17733516282731333019,8,2015
"Engineering the immune system to cure genetic diseases, HIV, and cancer","MH Porteus, A Fischer","Current opinion in immunology 5 (24), 576-579",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14014422704024797401,8,2012
Testing a three-finger zinc finger nuclease using a GFP reporter system,M Porteus,"Cold Spring Harbor Protocols 2010 (12), pdb. prot5531",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11145683793911159544,8,2010
Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification,"S Vaidyanathan, KT Azizian, AKMA Haque, JM Henderson, A Hendel, ...","Molecular Therapy-Nucleic Acids 12, 530-542",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8541303197073483080,7,2018
Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination,"RM Martin, K Ikeda, MK Cromer, N Uchida, T Nishimura, R Romano, ...","Cell stem cell 24 (5), 821-828. e5",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8666158716405985642,6,2019
Optimization of CRISPR/Cas9 delivery to human hematopoietic stem and progenitor cells for therapeutic genomic rearrangements,"A Lattanzi, V Meneghini, G Pavani, F Amor, S Ramadier, T Felix, ...","Molecular Therapy 27 (1), 137-150",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4580819888883328846,6,2019
Human Mesenchymal Stromal Cells Engineered to Overexpress PDGF-B Using CRISPR/Cas9/rAAV6-based Tools Improve Wound Healing,"N Kosaric, W Srifa, GC Gurtner, MH Porteus",Plastic and Reconstructive Surgery Global Open 5 (4 Suppl),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15354095554226427026,6,2017
Translating the lessons from gene therapy to the development of regenerative medicine,M Porteus,"Molecular Therapy 19 (3), 439-441",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12608974704750460030,6,2011
Closing in on treatment for hemophilia B,M Porteus,"New England Journal of Medicine 377 (23), 2274-2275",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=420392957855762967,5,2017
A pediatric case of T‐cell prolymphocytic leukemia,"B Mitton, S Coutre, J Willert, K Schlis, M Porteus, S Kharbanda, ...","Pediatric blood & cancer 62 (6), 1061-1062",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14026666584449496769,5,2015
Non-disruptive gene targeting,"MA Kay, M Porteus, J Barker, J Checketts, R Voit, A Barzel","US Patent App. 13/838,927",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2440269060557623116,5,2013
Creating zinc finger nucleases to manipulate the genome in a site-specific manner using a modular-assembly approach,M Porteus,"Cold Spring Harbor Protocols 2010 (12), pdb. top93",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1550618703836447740,5,2010
Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease,"SH Park, CM Lee, DP Dever, TH Davis, J Camarena, W Srifa, Y Zhang, ...","Nucleic Acids Research 47 (15), 7955-7972",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17710273117276360323,4,2019
Preclinical development of HBB gene correction in autologous hematopoietic stem and progenitor cells to treat severe sickle cell disease,"DP Dever, J Camarena, C Lee, C Vakulskas, M Behlke, G Bao, M Porteus","Blood 130 (Suppl 1), 4620-4620",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9456333985969876835,4,2017
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated disruption of the β-globin locus architecture,"C Antoniani, V Meneghini, A Lattanzi, G Pavani, T Felix, F Amor, ...","Blood 128 (22), 321-321",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6221774488036133506,4,2016
Strategies to increase genome editing frequencies and to facilitate the identification of edited cells,M Porteus,"Chromosomal Mutagenesis, 281-289",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17881808532764480491,4,2015
Seeing the light: integrating genome engineering with double-strand break repair,M Porteus,"Nature methods 8 (8), 628",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2826477605845309881,4,2011
Creating zinc finger nucleases using a modular-assembly approach,M Porteus,"Cold Spring Harbor Protocols 2010 (12), pdb. prot5530",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17952389418614784932,4,2010
AAV6 is superior to Clade F AAVs in stimulating homologous recombination-based genome editing in human HSPCs,"AM Dudek, MH Porteus","Molecular Therapy 27 (10), 1701-1705",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3584865144496763357,3,2019
Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I,"N Gomez-Ospina, SG Scharenberg, N Mostrel, RO Bak, S Mantri, ...","Nature communications 10 (1), 1-14",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14320794970533106720,3,2019
Interferon priming is essential for human CD34+ cell-derived plasmacytoid dendritic cell maturation and function,"A Laustsen, RO Bak, C Krapp, L Kjær, JH Egedahl, CC Petersen, S Pillai, ...","Nature communications 9 (1), 1-14",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6833180364347025559,3,2018
"Genotype, phenotype and T cell counts at one year predict survival and long term immune reconstitution after transplantation in severe combined immune deficiency (SCID)—the …","E Haddad, BR Logan, LM Griffith, RH Buckley, RE Parrott, CC Dvorak, ...","Biology of Blood and Marrow Transplantation 23 (3), S133-S134",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8103020667747634654,3,2017
Genome Editing for the β-Hemoglobinopathies,MH Porteus,"Gene and Cell Therapies for Beta-Globinopathies, 203-217",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7977173016410630174,3,2017
Gene editing with Crispr-Cas9 for treating beta-hemoglobinopathies,"C Lee, G Bao, MH Porteus, T Cornu, A Miccio, T Cradick, T Cathomen, ...","Blood 126 (23), 3376-3376",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2469208296297137913,3,2015
Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis,"FRS de Sio, L Passerini, S Restelli, MM Valente, A Pramov, ME Maccari, ...","Journal of Allergy and Clinical Immunology 142 (6), 1909-1921. e9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13353344523984907693,2,2018
Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis.,"FR Santoni de Sio, L Passerini, S Restelli, MM Valente, A Pramov, ...",J. allergy clin. immunol,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=445207244760770517,2,2018
"Selection-free, high frequency genome editing by homologous recombination of human pluripotent stem cells using Cas9 RNP and AAV6","R Martin, K Ikeda, N Uchida, MK Cromer, T Nishimura, DP Dever, ...","bioRxiv, 252163",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16943114327212136374,2,2018
Human bone marrow-derived mesenchymal stromal cells engineered to overexpress Pdgf-B using Crispr/Cas9/6aav6-Based tools accelerate wound healing in the murine Db/Db diabetic model,"W Srifa, N Kosaric, GC Gurtner, MH Porteus","WOUND REPAIR AND REGENERATION 25 (4), A37-A37",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13918582803491798030,2,2017
Genome Editing: The Next Step in Gene Therapy,"T Cathomen, M Hirsch, M Porteus",Springer,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=680346957330546494,2,2016
Nuclease mediated targeted genome modification in mammalian cells,"JC Barker, RA Voit, MH Porteus","Site-directed insertion of transgenes, 327-352",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1962655134086851301,2,2013
Candidate gene analysis of non-syndromic cleft-lip with or without cleft-palate (NS-CL/P) and cleft palata only (NS-CPO) in humans,"A Lidral, A Basart, P Romitti, T Parnell, T Doetschman, J Rubenstein, ...",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8234895005445250254,2,1995
CRISPR/Cas9 Genome Engineering in Engraftable Human Brain-Derived Neural Stem Cells,"DP Dever, SG Scharenberg, J Camarena, EJ Kildebeck, JT Clark, ...","iScience 15, 524-535",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2730697475707288070,1,2019
Highly Efficient Repair of the ΔF508 Mutation in Airway Stem Cells of Cystic Fibrosis Patients with Functional Rescue of the Differentiated Epithelia,"S Vaidyanathan, AA Salahudeen, ZM Sellers, DT Bravo, SS Choi, ...","bioRxiv, 561183",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6329984258404768675,1,2019
Protect NIH's DNA advisory committee.,"ZN Adelman, LM Albritton, K Boris-Lawrie, MJ Buchmeier, P Cannon, ...","Science (New York, NY) 362 (6413), 409",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12896925642172956411,1,2018
Use of chimeric nucleases to stimulate gene targeting,"D Baltimore, M Porteus","US Patent App. 10/006,053",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12070628826476958081,1,2018
Genome editing using CRISPR/Cas9 and rAAV6 to functionally correct Wiskott-Aldrich syndrome in human HSPCs,"V Wiebking, S Mantri, KI Weinberg, MH Porteus","MOLECULAR THERAPY 26 (5), 376-377",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17826893336555349057,1,2018
FOXP3 gene transfer in T cells and FOXP3 gene editing in HSC as novel treatment options for IPEX syndrome,"M Goodwin, Y Sato, L Passerini, F Barzaghi, E Lee, SK Suzette, ...","JOURNAL OF CLINICAL IMMUNOLOGY 38 (3), 427-427",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8033783369770441261,1,2018
Re-creating hereditary persistence of fetal hemoglobin with CRISPR/CAS9 to treat sickle cell disease and beta-thalassemia,"M Lin, E Paik, B Mishra, S Chou, D Burkhardt, A Kernytsky, M Pettiglio, ...","Haematologica 102, 23-24",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13494853757596977287,1,2017
Viral and non-viral delivery of the CRISPR-Cas9 system in human hematopoietic stem and progenitor cells,"A Lattanzi, V Meneghini, G Pavani, F Amor, C Antoniani, C Lee, M Porteus, ...","MOLECULAR THERAPY 25 (5), 299-299",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7114557061592792174,1,2017
Anti-Fungal Prophylaxis Using Intermediate Dose Ambisome Is Associated with Delayed Methotrexate Clearance in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell …,"LM Schultz, K Kumar, S Stone, E Callard, J Witkowski, L Shinn, L Pinner, ...","Blood 128 (22), 5762-5762",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18179693467463975093,1,2016
Invasive fungal disease in pediatric patients undergoing allogeneic hematopoietic stem cell transplant,"C Aftandilian, K Weinberg, J Willert, S Kharbanda, M Porteus, ...","Journal of pediatric hematology/oncology 38 (7), 574-580",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3767342467622161263,1,2016
Knock-in editing: it functionally corrects!,MH Porteus,"Blood 127 (21), 2507-2509",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12416294739714641037,1,2016
559. Induction of Fetal Hemoglobin in Adult Erythroblasts by Genome Editing of the Beta-Globin Locus,"C Antoniani, A Lattanzi, G Pavani, V Meneghini, E Magrin, L Weber, ...","Molecular Therapy 24, S223-S224",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10571179289295317350,1,2016
Supplement to: Transplantation of 240 patients with Severe Combined Immunodeficiency (SCID) from 2000-2009: A Primary Immune Deficiency Treatment Consortium report,"SY Pai, B Logan, L Griffith, R Buckley, R Parrott, C Dvorak, N Kapoor, ...",The New England Journal of Medicine 371 (5),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7121700110532932974,1,2014
Retrospective study of 240 patients with severe combined immunodeficiency transplanted from 2000-2009: a report from the primary immune deficiency treatment consortium of North …,"SY Pai, BR Logan, LM Griffith, RH Buckley, RE Parrott, CC Dvorak, ...","Biology of Blood and Marrow Transplantation 20 (2), S24-S25",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9441785948176846203,1,2014
Fine-Mapping and Genome Editing Reveal An Essential Erythroid Enhancer At The HbF-Associated ,"DE Bauer, SC Kamran, S Lessard, J Xu, Y Fujiwara, C Lin, Z Shao, ...","Blood, The Journal of the American Society of Hematology 122 (21), 437-437",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14131138198683250345,1,2013
Using Genome Engineering To Prospectively Investigate The Pathogenesis Of ,"EH Breese, C Dawson, C Buechele, MR Breese, ML Cleary, MH Porteus","Blood, The Journal of the American Society of Hematology 122 (21), 3722-3722",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=346883893095424131,1,2013
Zinc fingers on target: the existing methods of creating genetically modified plants are inefficient and imprecise. Zinc-finger technology offers the prospect of opening up a …,MH Porteus,"Nature 459 (7245), 337-339",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16648946284067128416,1,2009
Functional significance of U2AF1 S34F mutations in lung adenocarcinomas,"MS Esfahani, LJ Lee, YJ Jeon, RA Flynn, H Stehr, AB Hui, N Ishisoko, ...","Nature Communications 10 (1), 1-13",,0,2019
"High-Efficiency, Selection-free Gene Repair in Airway Stem Cells from Cystic Fibrosis Patients Rescues CFTR Function in Differentiated Epithelia","S Vaidyanathan, AA Salahudeen, ZM Sellers, DT Bravo, SS Choi, ...",Cell Stem Cell,,0,2019
Reply to “Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors”,"AM Dudek, MH Porteus","Molecular Therapy 27 (12), 2063",,0,2019
Adenylate Kinase 2 Links Energy Metabolism and Cell Fate in Hematopoietic Stem and Progenitor Cells,"W Wang, A Awani, A Devilbiss, T Mathews, D Thomas, DP Dever, ...","Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …",,0,2019
High-efficiency CRISPR induction of t (9; 11) chromosomal translocations and acute leukemias in human blood stem cells,"J Jeong, A Jager, P Domizi, M Pavel-Dinu, L Gojenola, M Iwasaki, ...","Blood advances 3 (19), 2825-2835",,0,2019
genome editing of graft-derived T cells for post-transplant immunotherapy in combination with TCR alpha beta (+)/CD19 (+)-depleted haploidentical HSCT,"V Wiebking, CM Lee, N Mostrel, RO Bak, G Bao, A Bertaina, MH Porteus","BONE MARROW TRANSPLANTATION 54, 183-184",,0,2019
INHIBITION OF NEMO-LIKE KINASE IMPROVES ERYTHROPOIESIS IN MODELS OF DIAMOND BLACKFAN ANEMIA,"K Takasaki, M Wilkes, J Chen, K Siva, G Varetti, D Dever, M Youn, ...",PEDIATRIC BLOOD & CANCER 66,,0,2019
RETRO-ORBITAL INFUSION OF HUMAN MESENCHYMAL STROMAL CELLS ACCELERATES WOUND HEALING THROUGH SYSTEMIC EFFECTS,"N Kosaric, W Srifa, H Kiwanuka, M Porteus, G Gurtner","WOUND REPAIR AND REGENERATION 27 (3), A10-A10",,0,2019
Advantages of DNA Barcoding versus Integration Site Analysis for In Vivo Clone Tracking after Transplantation,"MR Enstrom, JE Adair, KG Haworth, L Schefter, K Tam, MH Porteus, ...","MOLECULAR THERAPY 27 (4), 198-199",,0,2019
Targeting beta-Globin Gene into alpha-Globin Locus in Human Hematopoietic Stem and Progenitor Cells,"MK Cromer, J Camarena, RM Martin, BJ Lesch, VT Lemgart, RO Bak, ...","MOLECULAR THERAPY 27 (4), 400-400",,0,2019
Efficient Genome Editing of the PKLR Locus in Human Long-Term Hematopoietic Stem Cells Using Specific CRISPR/CAS9 RNP and AAV6-Delivery of Donor Templates to Treat Pyruvate …,"S Fananas-Baquero, O Quintana-Bustamante, O Alberquilla, ...","MOLECULAR THERAPY 27 (4), 451-451",,0,2019
Genome Edited Airway Stem Cells as a Durable Cell-Based Therapy to Treat Cystic Fibrosis,"S Vaidyanathan, ZM Sellers, DT Bravo, W Le, JV Nayak, MH Porteus","MOLECULAR THERAPY 27 (4), 83-83",,0,2019
Towards The Clinical Translation of Gene Correction in Hematopoietic Stem Cells for Sickle Cell Disease Treatment,"A Lattanzi, DP Dever, J Camarena, P Lahiri, H Segal, N Talbott, W Srifa, ...","MOLECULAR THERAPY 27 (4), 448-448",,0,2019
Genome Edited Human Hematopoietic Stem Cells Correct Lysosomal Storage Disorders: Proof-of-Concept and Safety Studies for Mucopolysaccharidosis Type I and Gaucher Disease,"N Gomez-Ospina, SG Scharenberg, N Mostrel, N Raj, L Attardi, S Khan, ...","MOLECULAR THERAPY 27 (4), 329-329",,0,2019
"Can't Live without"" U"": Genetic Engineering of UMPS to Create Auxotrophy in Human Cells","V Wiebking, JO Patterson, R Martin, MK Chanda, CM Lee, W Srifa, G Bao, ...","MOLECULAR THERAPY 27 (4), 454-454",,0,2019
Barcoded Clonal Tracking of CRISPR-Cas9 and rAAV6-Mediated Gene Targeting in Human Hematopoietic Stem and Progenitor Cells,"DP Dever, R Sharma, CM Lee, A Aziz, T Koehnke, J Camarena, Y Pan, ...","MOLECULAR THERAPY 27 (4), 5-5",,0,2019
"Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis (vol 142, pg 1909, 2018)","FRS de Sio, L Passerini, S Restelli, MM Valente, A Pramov, ME Maccari, ...","JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 143 (3), 1269-1269",,0,2019
Nuclease-Mediated Genome Editing of Primary Cells and Enrichment Thereof,"DP Dever, RO Bak, A Hendel, W Srifa, MH Porteus","US Patent App. 15/927,750",,0,2019
Efficient scarless genome editing in human pluripotent stem cells,"K Ikeda, N Uchida, T Nishimura, J White, RM Martin, H Nakauchi, ...","Nature methods 15 (12), 1045",,0,2018
Gene editing of PKLR gene in hematopoietic cells for the efficient correction of pyruvate kinase deficiency,"S Fananas-Baquero, O Quintana-Bustamante, O Alberquilla, ...","HUMAN GENE THERAPY 29 (12), A111-A111",,0,2018
"Changing the Face of Modern Medicine: Stem Cell and Gene Therapy Organized Jointly by the European Society of Gene & Cell Therapy (ESGCT), International Society for Stem Cell …","KM Champion, P Albertini, I Visigalli, F Cecere, N Carriglio, ...","Human Gene Therapy 29 (12), A1-A169",,0,2018
An Engineered Cell-Traceable Model of Reticular Dysgenesis in Human Hematopoietic Stem Cells Linking Metabolism and Differentiation,"W Wang, A Awani, L Reich, Y Nakauchi, D Thomas, DP Dever, M Porteus, ...","Blood 132 (Suppl 1), 2558-2558",,0,2018
Pharmacological Inhibition of Nlk (Nemo-like Kinase) Rescues Erythropoietic Defects in Pre-Clinical Models of Diamond Blackfan Anemia,"MC Wilkes, J Chen, K Siva, G Veretti, DP Dever, M Youn, HD Chae, ...","Blood 132 (Suppl 1), 754-754",,0,2018
Efficient CRISPR/Cas9-Mediated Gene Editing of Pklr in Human Hematopoietic Progenitors and Stem Cells for the Gene Therapy of Pyruvate Kinase Deficiency,"OQ Bustamante, S Fañanas-Baquero, DP Dever, A Omaira, J Camarena, ...","Blood 132 (Suppl 1), 5792-5792",,0,2018
Correction: Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6,"RO Bak, DP Dever, A Reinisch, DC Hernandez, R Majeti, MH Porteus","Elife 7, e43690",,0,2018
"Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6 (vol 6, e27873, 2017)","RO Bak, DP Dever, A Reinisch, DC Hernandez, R Majeti, MH Porteus",ELIFE 7,,0,2018
Transplantation: SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery,"E Haddad, BR Logan, LM Griffith, RH Buckley, RE Parrott, SE Prockop, ...","Blood 132 (17), 1737",,0,2018
Materials and methods for treatment of hemoglobinopathies,"MH Porteus, MR Allen, CA Cowan, AS Lundberg, I Michelle, LIN Ching, ...","US Patent App. 15/762,700",,0,2018
Mapping the Cellular Heterogeneity of CD34-Selected Umbilical Cord Blood Products,"S Mantri, A Reinisch, K Weinberg, D Lyell, D DiGiusto, R Agarwal-Hashmi, ...","BONE MARROW TRANSPLANTATION 53, 505-507",,0,2018
The Binns Program for Cord Blood Research: a novel program for cord blood procurement in an academic setting for biomedical research,"S Mantri, D Lyell, D DiGiusto, M Porteus, R Agarwal-Hashmi","BONE MARROW TRANSPLANTATION 53, 787-788",,0,2018
Materials and methods for treatment of human genetic diseases including hemoglobinopathies,MH Porteus,"US Patent App. 15/550,954",,0,2018
20 Therapeutic Genome Editing in Human Hematopoietic Stem and Progenitor Cells,"RO Bak, DP Dever, MH Porteus","Genome Editing and Engineering: From TALENs, ZFNs and CRISPRs to Molecular …",,0,2018
Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Regulation,"MH Porteus, A Hendel, J Clark, RO Bak, DE Ryan, DJ Dellinger, R Kaiser, ...","US Patent App. 15/724,073",,0,2018
CRISPR-Mediated Targeted Insertion of Cybb cDNAs into the Cybb Locus for Correction of X-CGD Patient CD34 (+) Cells,"CL Sweeney, U Choi, M Pavel-Dinu, S Koontz, L Li, N Theobald, J Lee, ...","MOLECULAR THERAPY 26 (5), 233-233",,0,2018
Induction of Fetal Hemoglobin Synthesis by CRISPR/Cas9-mediated Editing of the Human beta-globin Locus,"V Meneghini, A Lattanzi, C Antoniani, T Felix, O Romano, E Magrin, ...","MOLECULAR THERAPY 26 (5), 378-378",,0,2018
CRISPR-Mediated Genetic Engineering of Human Mesenchymal Stromal Cells for Therapeutic Protein Delivery in Chronic Wounds,"W Srifa, N Kosaric, G Gurtner, M Porteus","MOLECULAR THERAPY 26 (5), 33-34",,0,2018
Genome Editing for IL-10 Deficiency in Purified Hematopoietic Stem Cells,"R Romano, M Pavel-Dinu, R Bacchetta, MH Porteus, MG Roncarolo","MOLECULAR THERAPY 26 (5), 237-238",,0,2018
Genome Editing of Long-Term Human Hematopoietic Stem Cells for X-Linked Severe Combined Immunodeficiency,"M Pavel-Dinu, V Wiebking, BT Dejene, W Srifa, S Mantri, C Nicolas, ...","JOURNAL OF CLINICAL IMMUNOLOGY 38 (3), 365-366",,0,2018
Engineering blood stem cells for autologous transplants for lysosomal diseases: Correction of mucopolysaccharidosis type I using genome-edited hematopoietic stem and progenitor …,"N Gomez-Ospina, SG Scharenberg, S Mantri, C Nicolas, ROBO Bak, ...","Molecular Genetics and Metabolism 123 (2), S54-S55",,0,2018
Materials and methods for treatment of hemoglobinopathies,"MH Porteus, TJ Cradick, G Bao, CM Lee","US Patent App. 15/550,951",,0,2018
Materials and methods for treatment of hemoglobinopathies,MH Porteus,"US Patent App. 15/550,943",,0,2018
Priming Human Hematopoietic Stem and Progenitor Cells for Cas9/Sgrna and rAAV6-Mediated Homologous Recombination,"J Camarena, CT Charlesworth, MK Cromer, S Vaidyanathan, RO Bak, ...","Blood 130 (Suppl 1), 3342-3342",,0,2017
"ESGCT XXV Anniversary Congress in Collaboration with the German Society for Gene Therapy October 17–20, 2017 Berlin, Germany","SM Maffioletti, S Sarcar, A Henderson, I Mannhardt, L Pinton, LA Moyle, ...","Human Gene Therapy 28 (12), A1-A125",,0,2017
Engineering complex genotypes in primary haematopoietic cells using Cas9/sgRNA and AAV donor vectors,"RO Bak, DP Dever, A Reinisch, D Cruz, R Majeti, MH Porteus","HUMAN GENE THERAPY 28 (12), A17-A17",,0,2017
Genome editing of human neural stem cells using nucleases,"MH Porteus, EJ Kildebeck, DP Dever, JT Clark, A Tsukamoto, N Uchida","US Patent App. 15/487,309",,0,2017
CD9 surface expression marks human MLL rearranged cells generated by genome editing,"C Schneidawind, J Jeong, D Schneidawind, EH Breese, M Porteus, ...","ONCOLOGY RESEARCH AND TREATMENT 40, 144-144",,0,2017
Genome editing of primary human HSPCs generates MLL leukemias charcterized by CD9 surface expression,"C Schneidawind, J Jeong, D Schneidawind, EH Breese, M Porteus, ...","ONCOLOGY RESEARCH AND TREATMENT 40, 51-+",,0,2017
Non-disruptive gene targeting,"MA Kay, M Porteus, J Barker, J Checketts, R Voit, A Barzel","US Patent App. 15/457,923",,0,2017
Multiplexing CRISPR-Cas9 Genome Editing in Human Hematopoietic Stem and Effector Cells,"DP Dever, RO Bak, A Reinisch, D Cruz, R Majeti, M Porteus","MOLECULAR THERAPY 25 (5), 343-343",,0,2017
High Frequency of Sero-Positivity of IgG Antibodies Against Cas9 Protein in Humans,"CT Charlesworth, D Dever, N Gomez-Ospina, S Mantri, M Pavel-Dinu, ...","MOLECULAR THERAPY 25 (5), 168-168",,0,2017
CRISPR-Based Gene Correction to Treat IPEX Syndrome,"M Goodwin, S Shipp, L Froessl, M Porteus, MG Roncarolo, R Bacchetta","MOLECULAR THERAPY 25 (5), 168-168",,0,2017
Correction of X-Linked Severe Combined Immunodeficiency in Human Hematopoietic Stem and Progenitor Cells,"M Pavel-Dinu, VA Wiebking, N Gomez-Ospina, RO Bak, BT Dejene, ...","MOLECULAR THERAPY 25 (5), 345-346",,0,2017
Priming Hematopoietic Stem and Progenitor Cells for CRISPR/Cas9-Mediated Homologous Recombination,"J Camarena, CT Charlesworth, RO Bak, J Carte, J Potter, DD Dever, ...","MOLECULAR THERAPY 25 (5), 78-78",,0,2017
Use of chimeric nucleases to stimulate gene targeting,"D Baltimore, M Porteus","US Patent App. 15/259,848",,0,2017
Anti-Fungal Prophylaxis Using Intermediate Dose Ambisome is Associated with Delayed Methotrexate Clearance in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell …,"L Schultz, K Kumar, S Stone, E Callard, J Witkowski, L Shinn, L Pinner, ...","Biology of Blood and Marrow Transplantation 23 (3), S297-S298",,0,2017
Beta-Globin Gene Targeting in Human Hematopoietic Stem Cells Using Cas9 Ribonucleoprotein and rAAV6,"DP Dever, M Porteus","Blood 128 (22), 2310-2310",,0,2016
Re-Creating Hereditary Persistence of Fetal Hemoglobin (HPFH) to Treat Sickle Cell Disease (SCD) and β-Thalassemia,"MI Lin, EJ Paik, BP Mishra, S Chou, Y Zhang, K Tomkinson, MA Pettiglio, ...","Blood 128 (22), 4708-4708",,0,2016
Dual-Method Clone Tracking in Nonhuman Primates Confirms Long-Term Hematopoietic Reconstitution Initiated By Early Engrafting Clones,"JE Adair, ZK Norgaard, KG Haworth, LE Schefter, K Tam, M Porteus, ...","Blood 128 (22), 1475-1475",,0,2016
Viral and non-viral delivery of the CRISPR/Cas9 system in human hematopoietic stem and progenitor cells (HSPC),"A Lattanzi, C Antoniani, C Lee, G Pavani, F Amor, TJ Cradick, ...","HUMAN GENE THERAPY 27 (11), A140-A140",,0,2016
"Changing the Face of Modern Medicine: Stem Cells and Gene Therapy Florence, Italy October 18–21, 2016 Abstracts","JC Ramírez, AB del Campo, A Pañeda, I Jiménez, A Berlanga, A Mork, ...","Human Gene Therapy 27 (11), A1-A185",,0,2016
CD9 surface expression marks human MLL rearranged cells generated by genome editing,"C Schneidawind, J Jeong, D Schneidawind, EH Breese, M Porteus, ...","ONCOLOGY RESEARCH AND TREATMENT 39, 144-144",,0,2016
563. Analysis of DNA Repair Pathway Choice Upon Induction of Double-Strand Breaks by Engineered Nuclease,"RI Kumaran, J Li, WS Dynan, MH Porteus, DL Spector","Molecular Therapy 24, S225",,0,2016
128. Targeting a High-Expression FVIII Transgene to Exogenous Locations in the Genome without Disrupting Endogenous Gene Expression,"JM Johnston, M Porteus","Molecular Therapy 24, S52-S53",,0,2016
123. Gene Editing as a Therapeutic Approach to Treat IPEX Syndrome,"M Goodwin, FS de Sio, D Dever, M Porteus, MG Roncarolo, R Bacchetta","Molecular Therapy 24, S51",,0,2016
43. CRISPR/Cas9 and rAAV6-Mediated Targeted Integration at the CCR5 Locus in Hematopoietic Stem and Progenitor Cells,"RO Bak, DP Dever, N Saxena, J Camarena, A Reinisch, AB Wilkens, ...","Molecular Therapy 24, S19",,0,2016
39. FACS-Based Enrichment of a Highly Purified HBB-Targeted Hematopoietic Stem and Progenitor Cell Population Using rAAV6 and CRISPR/Cas9,"DP Dever, RO Bak, J Camarena, N Saxena, A Reinisch, CE Nicolas, ...","Molecular Therapy 24, S17",,0,2016
Abstract IA04: Using genome editing to model MLL rearranged leukemias,"E Breese, C Buechele, M Cleary, M Porteus","Cancer Research 76 (5 Supplement), IA04-IA04",,0,2016
Invasive Fungal Disease in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant,"S Kharbanda, M Porteus",,,0,2016
Chemically synthesized modified guide RNAs enhance CRISPR/cas9 genome editing,"J Myerson, AB Kennedy, DE Ryan, SM Phadnis, CW Yung, RO Bak, ...","Synthetic Biology: Engineering, Evolution, and Design Conference 2016, SEED …",,0,2016
Advances in Genome Editing,"JA Doudna, W Tan, MH Porteus, D Carroll, CY Park, J Kim","Advances in Genome Editing, 334",,0,2016
Genome Editing The Next Step in Gene Therapy Preface,"T Cathomen, ML Hirsch, M Porteus","GENOME EDITING: THE NEXT STEP IN GENE THERAPY 895, VII-VIII",,0,2016
"ESGCT and FSGT Collaborative Congress Helsinki, Finland September 17–20, 2015 Abstracts","S Sultan, A Reginald, MJ Evans, P Antonitsis, S Westaby, K Anastasiadis, ...","Human Gene Therapy 26 (10), A-1-A-108",,0,2015
GENERATION OF A BRONCHIAL EPITHELIAL CELL LINE WITH DEFINED CFTR MUTATIONS BY NUCLEASE-ENHANCED SDF-MEDIATED HOMOLOGOUS REPLACEMENT FROM NON-CF 16HBE14O-CELLS: 186,"S Suzuki, R Di Geronimo, C Tasto, A Guimaraes, B Illek, H Fischer, ...",Pediatric Pulmonology 50,,0,2015
A NOVEL APPROACH TO INVESTIGATING THE PATHOGENESIS OF ONCOGENIC TRANSLOCATIONS IN INFANT LEUKEMIA USING ENGINEERED NUCLEASES,"E Breese, C Buechele, M Cleary, M Porteus",Pediatric Blood & Cancer 62,,0,2015
Analysis of DNA repair pathway choice upon zinc finger nuclease induced double-strand breaks,"RI Kumaran, J Li, WS Dynan, MH Porteus, DL Spector",MOLECULAR BIOLOGY OF THE CELL 26,,0,2015
Novel Integrated Autologous Hematopoietic Stem Cell Tracking in Nonhuman Primates Reveals Successive Pattern of Multi-Lineage Reconstitution after Total Body Irradiation,"JE Adair, S Porter, K Haworth, K Tam, HP Kiem, MH Porteus","Blood 124 (21), 2910-2910",,0,2014
Genome Engineering to Prospectively Investigate the Pathogenesis of MLL-AF9 Acute Leukemia,"C Buechele, EH Breese, D Schneidawind, MH Porteus, ML Cleary","Blood 124 (21), 883-883",,0,2014
"A Comparison of Repair Pathway Choice between ZFNs, TALENs, and CRISPRs at Endogenous Loci via Simultaneous Measurement of NHEJ and HDR Using SMRT Sequencing","EJ Fine, A Hendel, EJ Kildebeck, CM Appleton, GC Washington, J Clark, ...","MOLECULAR THERAPY 22, S34-S34",,0,2014
"Novel Integrated Hematopoietic Clone Tracking in Nonhuman Primates Suggests a Minimal Population of Multipotential, Long-Term Repopulating Stem Cells in CD34-Enriched Cell Pools","JE Adair, SN Porter, MH Porteus, HP Kiem","MOLECULAR THERAPY 22, S286-S287",,0,2014
On-Target Cleavage and Off-Target Activity of TALEN'Nickases',"TJ Cradick, CJ Antico, EJ Fine, CR Lindsay, E Kildebeck, DB Roth, ...","MOLECULAR THERAPY 21, S125-S125",,0,2013
Quantifying Rates of Gene Targeting and Off-Target Cleavage of Engineered Nucleases Using SMRT Sequencing,"EJ Fine, E Kildebeck, Y Lin, MH Porteus, TJ Cradick, G Bao","MOLECULAR THERAPY 21, S189-S189",,0,2013
Correction of Delta F508 CFTR in Patient-Derived iPS Cells Using Small Frgement Homologous Replacement (SFHR) and Transcription Activator-Like Effector Nucleases (TALENs),"S Suzuki, TJ Cradick, RG Sargent, L Albert, M Porteus, G Bao, ...","MOLECULAR THERAPY 21, S181-S181",,0,2013
Single Institution Experience With Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients With Acute Leukemia,"E Breese, R Agarwal, S Kharbanda, M Breese, M Amylon, KI Weinberg, ...","Biology of Blood and Marrow Transplantation 19 (2), S242-S243",,0,2013
High Risk Allogeneic Hematopoietic Cell Transplant (HCT) Patients with Any Level of Cytomegalovirus (CMV) Viremia Should Be Treated with Antiviral Therapy to Prevent Serious …,"L Winestone, R Agarwal, KI Weinberg, M Porteus, JR Willert, M Amylon, ...","Biology of Blood and Marrow Transplantation 19 (2), S312",,0,2013
Hematopoietic Cell Transplantation (HCT) for Treatment of Genetic Lymphohematopoietic Diseases for Patients Lacking a Fully Matched Sibling Donor Using a Novel Conditioning Regimen,"S Kharbanda, R Agarwal, DB Miklos, M Porteus, M Amylon, JR Willert, ...","Biology of Blood and Marrow Transplantation 19 (2), S250-S251",,0,2013
Bortezomib As a Treatment for Autoimmune Cytopenia After Bone Marrow Transplant,"NR Lalefar, R Agarwal, MH Porteus, S Kharbanda, KI Weinberg","Biology of Blood and Marrow Transplantation 19 (2), S177",,0,2013
Illuminating Clonal Dynamics of a Leukemia Cell Line Using Viral Barcoding and Illumina Deep Sequencing Technology,"S Porter, G Highnam, D Mittelman, M Porteus","Blood 120 (21), 1410-1410",,0,2012
Population Dynamics of Acute Myeloid Leukemia Clones by Barcode Tracking and High Throughput Sequencing,"CH Hsu, S Porter, G Highnam, D Mittelman, MH Porteus","Blood 120 (21), 1398-1398",,0,2012
HbF-Associated Genetic Variation Marks an Erythroid Regulatory Element Essential for BCL11A Transcription and Subsequent Stage-Specific Globin Expression,"DE Bauer, SC Kamran, J Xu, C Lin, Z Shao, Y Fujiwara, RA Voit, ...","Blood 120 (21), 828-828",,0,2012
TREC NEWBORN SCREENING IN CALIFORNIA REVEALS A WIDE SPECTRUM OF T CELL LYMPHOPENIC DISORDERS,"A Kwan, J Church, M Cowan, TB Moore, N Kapoor, ER Stiehm, M Porteus, ...","JOURNAL OF CLINICAL IMMUNOLOGY 32, 307-308",,0,2012
Homologous-Recombination Mediated Genome Editing at the Adesonine Deaminase Locus in Patient-Derived Fibroblasts Using TAL Effector Nucleases,"JA Checketts, M Randar, MH Porteus","MOLECULAR THERAPY 20, S121-S121",,0,2012
Using Homologous Recombination To Stack Genetic Resistance to HIV,"RA Voit, S Sawyer, MH Porteus","MOLECULAR THERAPY 20, S121-S121",,0,2012
Safe Harbor Locus Preservation with Zinc-Finger Nuclease Mediated Gene Addition in Mouse Primary Fibroblasts,"JC Barker, LJ Huang, MH Porteus","MOLECULAR THERAPY 20, S52-S53",,0,2012
DNA Vector Development & Gene Targeting III,"A Barzel, R Voit, M Porteus, MA Kay","Molecular Therapy 20, 1",,0,2012
Engineered Nuclease Mediated Gene Targeting of the Human IL2R gamma Gene,"EJ Kildebeck, MH Porteus","MOLECULAR THERAPY 20, S89-S89",,0,2012
Gene Targeting of the Human Globin Loci Using Engineered Nucleases,"RA Voit, M Mansh, MH Porteus","MOLECULAR THERAPY 20, S121-S122",,0,2012
Targeting 2A-Fusions to Endogenous Genes,"A Barzel, R Voit, M Porteus, MA Kay","MOLECULAR THERAPY 20, S234-S234",,0,2012
Edición de genes: una nueva herramienta para la biología molecular,"MA McMahon, M Rahdar, M Porteus","Investigación y ciencia, 9-12",,0,2012
A Biological Delivery Platform for Zinc Finger Nucleases Using Transferrin-Mediated Endocytosis,"SE Meiler, WS Dynan, M Porteus, DL Spector, G Bao, Z Chen, J Pandey, ...","Blood 118 (21), 1071-1071",,0,2011
Zinc Finger Nuclease-Mediated Gene Targeting of Human Rhodopsin Mutations in Mice,"IM Sandoval, BA Price, F Chan, J Zhang, S Zhang, WW Hauswirth, ...","Investigative Ophthalmology & Visual Science 52 (14), 4375-4375",,0,2011
APPENDIX D. STANDARIZED REAGENTS AND PROTOCOLS FOR ENGINEERING ZINC FINGER NUCLEASES BY MODULAR ASSEBMLY,"DA Wright, S Thibodeau-Beganny, JD Sander, RJ Winfrey, AS Hirsh, ...",Computational approaches to understand interactions between zinc finger …,,0,2010
Homologous Recombination and Targeted Gene Modification for Gene Therapy,M Porteus,"A Guide To Human Gene Therapy, 139-161",,0,2010
Enhancement of Small Fragment Homologous Replacement (SFHR) Genomic DNA Modifi cation with Zinc Finger Nucleases,"H Parsi, H Emamekhoo, J Nguyen, MH Porteus, DC Gruenert","MOLECULAR THERAPY 17, S388-S388",,0,2009
"246. Clearance of Adenovirus by Kupffer Cells Is Mediated by Natural Antibodies, Complement and Scavenger Receptors","KA Wilson, AE McEwen, SM Pruett, MH Porteus","Molecular Therapy 16, 1",,0,2008
Maximizing Translation of Cas9 mRNA Therapeutics by Sequence Engineering and Chemical Modification,"S Vaidyanathan, KT Azizian, J Henderson, D Shin, A Lebedev, RI Hogrefe, ...","Mol Ther 11, 1833-40",,0,2008
Using zinc-finger nuclease mediated homologous recombination to manipulate the mammalian genome.,MH Porteus,"IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL 42, 3A-3A",,0,2006
709. Gene correction and gene knockouts in human somatic cells using zinc finger nucleases,MH Porteus,"Molecular Therapy 9 (S1), S270",,0,2004
Chimeric nucleases stimulate gene targeting in human cells,"M Porteus, D Baltimore","Blood 100 (11), 219A",,0,2002
Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: A report from the National Wilms Tumor Study Group,"MH Porteus, P Narkool, D Neuberg, K Guthrie, N Breslow, DM Green, ...","JOURNAL OF UROLOGY 168 (1), 382-383",,0,2002
ORIGINAL REPORTS-Pediatric Oncology-Characteristics and Outcome of Children With Beckwith-Wiedemann Syndrome and Wilms' Tumor: A Report From the National Wilms Tumor Study Group,"MH Porteus, P Narkool, D Neuberg, K Guthrie, N Breslow, DM Green, ...","Journal of Clinical Oncology 18 (10), 2026-2031",,0,2000
Isolation and characterization ofTes-1/Dlx-2: A novel homeobox gene expressed during mammalian forebrain development.,MH Porteus,,,0,1995
"CHARACTERIZATION OF THE GENOMIC STRUCTURE OF DLX-1 AND DLX-2, 2 CLOSELY LINKED HOMEOBOX GENES EXPRESSED IN THE DEVELOPING MAMMALIAN FOREBRAIN","TL MCGUINNESS, A BULFONE, MH PORTEUS, JLR RUBENSTEIN","CLINICAL RESEARCH 42 (2), A259-A259",,0,1994
"Armstrong, JF, Pritchard-Jones, K., Bickmore, WA, Hastie, ND and Bard, JBL The expression of the Wilms' tumour gene, WT1, in the develop-ing mammalian embryo (40) 85","S Baumgartner, R Chiquet-Ehrismann, LC Bradley, A Snape, S Bhatt, ...","Mechanisms of Development 40 (195), 195",,0,1993
A Comprehensive TALEN-Based Knockout Library for Generating Human-Induced Pluripotent Stem Cell-Based Models f or Cardiovascular Diseases.,"I Karakikes, V Termglinchan, DA Cepeda, J Lee, S Diecke, A Hendel, ...",,,0,0
Supplemental Data Gene Targeting of a Disease-Related Gene in Human-Induced Pluripotent Stem and Embryonic Stem Cells,"J Zou, ML Maeder, P Mali, SM Pruett-Miller, S Thibodeau-Beganny, ...",,,0,0
62 Looking forward to genetically edited fruit crops,"ME Maffei, M Malnoy, B Geering, M Fussenegger, D Schmidt, YK Cho, ...",,,0,0
Genome Editing,"T Cathomen, M Hirsch, M Porteus",,,0,0
TECHNICAL COMMENT ABSTRACTS,"EC Kirk, M Cartmill, RF Kay, P Lemelin, MH Porteus, D Baltimore",,,0,0
Phosphorylation of Residues Inside the SNARE Complex Terminates Secretory Vesicle Fusion,"S Malmersjö, S Di Palma, J Diao, Y Lai, R Pfuetzner, A Wang, ...",,,0,0
